Skip to main content

Logo
  • Live News iconLive News
  • Smart Screener iconSmart Screener
  • Trade Opportunities iconTrade Opportunities
  • Alpha Watch iconAlpha Watch
  • Catalyst iconCatalyst
Skip to main content
Stock Ask Logo
Hi, Guest User

Log in or create an account to get full access

Open an Account (opens in a new window)

TOOLS

Live News
Smart Screener
Trade Opportunities
Alpha Watch
Catalyst

StockkASK powered by Indira Securities

Influx Healthtech Ltd (INFLUX) Share Price & Fundamentals

Company Overview

Founded Year

2020

Listed Year

2025

Headquarter

Mumbai, Maharashtra, India

MD/CEO

-

Website

-

Company Facts

What we do

Influx Healthtech Ltd is a Mumbai-based healthcare manufacturer specializing in nutraceuticals, cosmetics, Ayurvedic, veterinary, and homecare products as a CDMO.

Founded in

2,020

Market share

-

Problem solved

Provides contract manufacturing and product development support for dietary and nutritional supplements, enabling brands to market diverse health and wellness products.

Top clients or who we serve

Small and medium marketing and distribution brands across nutraceuticals, cosmetics, Ayurvedic, veterinary, and homecare sectors (B2B).

Key management

-

Our journey and innovations

Incorporated in 2020, converted to public limited in 2022, and raised Rs 58.56 crore via public issue in 2025 to expand manufacturing capabilities.

Where we operate

Operations and manufacturing plants based in Thane, Maharashtra, serving pan-India clients and brands.

Top products or what we offer

Soft gelatin capsules, tablets, liquid orals, nutraceutical protein bars, Ayurvedic creams, veterinary feed supplements, and homecare products.

Top brands

-

Raw materials needed

-

Raw materials supplier

-

Recurring vs cyclical contribution

-

Our industry position

-

Financial highlights

FY 2024-25 Revenue Rs 104.85 crore; Net Profit Rs 13.37 crore, reflecting solid growth in healthcare manufacturing segment.

Geographical revenue split

-

Order book

-

Whats driving growth

Increasing demand for contract manufacturing in health supplements, government certifications, and expansion of nutraceutical and Ayurvedic markets.

Our future plans

Enhance production capacity and diversify product portfolio leveraging funds raised in June 2025 public issue.

Our green promise

-

Our people and values

-

Key challenges ahead

-

Interesting facts

-

Risks and strategy

-

Market Footprint

Top Clients

Top Clients

Small and medium marketing and distribution brands across nutraceuticals, cosmetics, Ayurvedic, veterinary, and homecare sectors (B2B).

Top Products

Top Products

Soft gelatin capsules, tablets, liquid orals, nutraceutical protein bars, Ayurvedic creams, veterinary feed supplements, and homecare products.

Price Movement & Share Holding

Today's High/Low

260271

52 Week High/Low

120336
Past Returns

1 week

2.82%

1 month

-0.31%

3 month

-6.88%

1 year

54.67%

3 year

113.99%

5 year

113.99%

Share Holding

Promoters

73.53%

FII

0.41%

DII

7.33%

Retail

16.21%

Others

2.51%

Company Overview

Founded Year

2020

Listed Year

2025

Headquarter

Mumbai, Maharashtra, India

MD/CEO

-

Website

-

Price Movement & Share Holding

Today's High/Low

260271

52 Week High/Low

120336

Past Returns

1 week

2.82%

1 month

-0.31%

3 month

-6.88%

1 year

54.67%

3 year

113.99%

5 year

113.99%

Share Holding

Promoters

73.53%

FII

0.41%

DII

7.33%

Retail

16.21%

Others

2.51%

Company Facts

What we do

Influx Healthtech Ltd is a Mumbai-based healthcare manufacturer specializing in nutraceuticals, cosmetics, Ayurvedic, veterinary, and homecare products as a CDMO.

Founded in

2020

Problem solved

Provides contract manufacturing and product development support for dietary and nutritional supplements, enabling brands to market diverse health and wellness products.

Top clients or who we serve

Small and medium marketing and distribution brands across nutraceuticals, cosmetics, Ayurvedic, veterinary, and homecare sectors (B2B).

Our journey and innovations

Incorporated in 2020, converted to public limited in 2022, and raised Rs 58.56 crore via public issue in 2025 to expand manufacturing capabilities.

Where we operate

Operations and manufacturing plants based in Thane, Maharashtra, serving pan-India clients and brands.

Top products or what we offer

Soft gelatin capsules, tablets, liquid orals, nutraceutical protein bars, Ayurvedic creams, veterinary feed supplements, and homecare products.

Financial highlights

FY 2024-25 Revenue Rs 104.85 crore; Net Profit Rs 13.37 crore, reflecting solid growth in healthcare manufacturing segment.

Whats driving growth

Increasing demand for contract manufacturing in health supplements, government certifications, and expansion of nutraceutical and Ayurvedic markets.

Our future plans

Enhance production capacity and diversify product portfolio leveraging funds raised in June 2025 public issue.

Market Footprint

Top Clients

Top Clients

Small and medium marketing and distribution brands across nutraceuticals, cosmetics, Ayurvedic, veterinary, and homecare sectors (B2B).

Top Products

Top Products

Soft gelatin capsules, tablets, liquid orals, nutraceutical protein bars, Ayurvedic creams, veterinary feed supplements, and homecare products.

StockkASK provides smart, AI-powered insights to support analysis. AI can make mistakes; verify independently before investing.Terms & Conditions